COBIOE
Financiado
GROWING CONNECTION FOR BIO ECOSYSTEMS
COBIOE is project to interconnect innovation ecosystems to foster 4.0 industrial transition in the biopharmaceutical deeptech sector, sharing competences, information and opportunities, with the aim of ultimately converging toward...
COBIOE is project to interconnect innovation ecosystems to foster 4.0 industrial transition in the biopharmaceutical deeptech sector, sharing competences, information and opportunities, with the aim of ultimately converging toward a common and inclusive European strategy for bioproduction support. Specifically, the proposition will focus on the bioproduction sector that includes development of small molecules, biologics, drugs, innovative therapeutics (such as gene and cellular therapies), high technology drugs based on cell and molecular biology, and covers various applications in health (oncology, immunology, virology, rare diseases, etc…).
COBIOE will reach the following objectives:
- Provide a state of the art and exploitable overview of the European bioproduction value chain, focusing on European, national, regional strategy or existing initiatives, activities
- Opening up the bioproduction field, by reaching out to isolated actors and territories bringing added value to the chain.
- Building up bridges between sparse innovative ecosystems and initiatives opening up opportunities for isolated players.
- Promote bioproduction ecosystems, the field and its potentialities in terms of green, digital and social transition, among various stakeholders and policymakers
COBIOE proposal includes 5 health clusters/networks, preeminent and pioneers in the field of pharmaceutical biomanufacturing. Each partner complements each other in terms of competence and the partnership covers almost all European regions from north to south and east to west, including modest, moderate, strong and leading innovators. Moreover, each partner benefits from an extended network of stakeholders, from different technological sectors (materials science, artificial intelligence, biotechnology, blockchain, robotics, photonics, electronics and quantum information) and actors (universities, research, hospitals, funders…).
ver más
Duración del proyecto: 26 meses
Fecha Inicio: 2022-12-16
Fecha Fin: 2025-02-28
Fecha Fin: 2025-02-28
Línea de financiación: concedida
El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2022-12-16
Línea de financiación objetivo
El proyecto se financió a través de la siguiente ayuda:
Presupuesto
El presupuesto total del proyecto asciende a
500K€
Líder del proyecto
GENOPOLE GIP
No se ha especificado una descripción o un objeto social para esta compañía.
Perfil tecnológico
TRL
4-5
Perfil tecnológico
TRL
4-5
74.19K€ |
Participante
90.63K€ |
Participante
91.14K€ |
Participante